Biden Announces Enough COVID Vaccine For All Adult Americans By End Of May

BURLINGTON, IA - AUGUST 07: Former Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa. (Photo by Tom Brenner/Getty Images)
BURLINGTON, IA - AUGUST 07: Democratic presidential candidate and former U.S. Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa... BURLINGTON, IA - AUGUST 07: Democratic presidential candidate and former U.S. Vice President Joe Biden delivers remarks about White Nationalism during a campaign press conference on August 7, 2019 in Burlington, Iowa. (Photo by Tom Brenner/Getty Images) MORE LESS

The U.S. has secured enough doses of COVID-19 vaccine to inoculate the country’s adult population by the end of May, President Joe Biden said on Tuesday.

The announcement means that the country will achieve the mark of enough doses for all adult Americans two months earlier than previously planned. Biden said last month that there would be enough for all Americans by the end of July, while forecasts at the start of his presidency initially suggested that the country would reach the milestone at the end of August.

“We’re now on track to have enough vaccine supply for every adult in America by the end of May,” Biden said in remarks from the White House.

The President added that the Trump administration had failed to secure enough doses of FDA-authorized vaccines to cover the country’s population at all. The Trump administration passed up an opportunity from pharmaceutical giant Pfizer to order millions of additional doses.

At the time, it was unclear whether any inoculations beyond the two-shot Pfizer and Moderna mRNA vaccine would work.

“The prior administration had contacted for not nearly enough vaccine to cover all the adults in America,” Biden said. “We rectified that.”

The U.S. is now on track to have far more vaccine than would be necessary to inoculate every American, after the FDA issued emergency use authorization for the Johnson & Johnson vaccine on Saturday.

The Biden administration has flexed federal muscles in both the manufacturing and deployment of the shots, including a program announced on Tuesday that will see Merck produce COVID-19 vaccines created by its competitor J&J.

Dear Reader,

When we asked recently what makes TPM different from other outlets, readers cited factors like honesty, curiosity, transparency, and our vibrant community. They also pointed to our ability to report on important stories and trends long before they are picked up by mainstream outlets; our ability to contextualize information within the arc of history; and our focus on the real-world consequences of the news.

Our unique approach to reporting and presenting the news, however, wouldn’t be possible without our readers’ support. That’s not just marketing speak, it’s true: our work would literally not be possible without readers deciding to become members. Not only does member support account for more than 80% of TPM’s revenue, our members have helped us build an engaged and informed community. Many of our best stories were born from reader tips and valuable member feedback.

We do what other news outlets can’t or won’t do because our members’ support gives us real independence.

If you enjoy reading TPM and value what we do, become a member today.

Sincerely,
TPM Staff
Latest News
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Newswriters:
Director of Audience:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: